Axi-cel outcomes among non-Hispanic Black patients

Blood. 2024 Jun 27;143(26):2681-2682. doi: 10.1182/blood.2024024959.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adult
  • Antineoplastic Agents, Immunological
  • Black or African American*
  • Female
  • Humans
  • Lymphoma, B-Cell / drug therapy
  • Male
  • Middle Aged

Substances

  • axicabtagene ciloleucel
  • Antineoplastic Agents, Immunological